BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34866847)

  • 21. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
    Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
    Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals.
    Mercan-Stanciu A; Isac T; Rababoc R; Rusie D; Toma L; Vacaroiu IA; Tulin R; Iliescu EL
    Cureus; 2022 May; 14(5):e25487. PubMed ID: 35800821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.
    Arora A; Sharma P; Tyagi P; Singla V; Arora V; Bansal N; Toshniwal J; Kumar A
    J Clin Exp Hepatol; 2013 Dec; 3(4):288-95. PubMed ID: 25755516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies.
    Yen YH; Kee KM; Hu TH; Tsai MC; Kuo YH; Li WF; Liu YW; Wang CC; Lin CY
    PLoS One; 2024; 19(3):e0290523. PubMed ID: 38489301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry.
    Lee SH; Jin YJ; Lee JW
    Medicine (Baltimore); 2017 Nov; 96(44):e8486. PubMed ID: 29095307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment.
    Ohama H; Hiraoka A; Tada F; Kato K; Fukunishi Y; Yanagihara E; Kato M; Saneto H; Izumoto H; Ueki H; Yoshino T; Kitahata S; Kawamura T; Kuroda T; Suga Y; Miyata H; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular Carcinoma in Malaysia and Its Changing Trend.
    Raihan R; Azzeri A; H Shabaruddin F; Mohamed R
    Euroasian J Hepatogastroenterol; 2018; 8(1):54-56. PubMed ID: 29963463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
    Hur MH; Lee JH; Kim JY; Hong JH; Park MK; Cho HJ; Choi NR; Kim J; Kim MA; Nam JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Lee DH; Lee JM; Hong SK; Yi NJ; Lee KW; Suh KS; Yoon JH
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
    Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
    Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Holzner ML; Florman S; Schwartz ME; Tabrizian P
    HPB (Oxford); 2022 Apr; 24(4):470-477. PubMed ID: 34544629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India.
    Jothimani D; Danielraj S; Narasimhan G; Kaliamoorthy I; Rajakumar A; Palaniappan K; Palanichamy S; Rammohan A; Ramachandran H; Rajalingam R; Rela M
    J Clin Exp Hepatol; 2022; 12(3):908-916. PubMed ID: 35677507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study.
    Ivanics T; Rajendran L; Abreu PA; Claasen MPAW; Shwaartz C; Patel MS; Choi WJ; Doyle A; Muaddi H; McGilvray ID; Selzner M; Beecroft R; Kachura J; Bhat M; Selzner N; Ghanekar A; Cattral M; Sayed B; Reichman T; Lilly L; Sapisochin G
    Ann Med Surg (Lond); 2022 May; 77():103645. PubMed ID: 35637985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.
    Ueno M; Hayami S; Shigekawa Y; Kawai M; Hirono S; Okada K; Tamai H; Shingaki N; Mori Y; Ichinose M; Yamaue H
    J Hepatol; 2015 Dec; 63(6):1352-9. PubMed ID: 26212030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.